Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma

FEBS Letters

Volumn 579, Issue 30, 2005, Pages 6885-6889

  Flygare, Jenny ^a   Gustafsson, Kristin ^a   Kimby, Eva ^a   Christensson, Birger ^a   Sander, Birgitta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Cannabinoid receptor; Growth; Mantle cell lymphoma; Viability

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; RIMONABANT;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; BIOPSY; BREAST NEOPLASMS; CANNABINOIDS; CELL DEATH; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, PLASMACYTIC; LIGANDS; LYMPHOMA, MANTLE-CELL; MICE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTORS, CANNABINOID;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 28844473489     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.11.020     Document Type: Article

References (21)

1. D. Decaudin Mantle cell lymphoma: a biological and therapeutic paradigm Leuk. Lymphoma 43 2002 773 781
2. S. Ek, C.M. Hogerkorp, M. Dictor, M. Ehinger, and C.A. Borrebaeck Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells Cancer Res. 62 2002 4398 4405
3. T.C. Islam High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma Leukemia 17 2003 1880 1890
4. A.C. Howlett International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
5. M. Guzman Cannabinoids: potential anticancer agents Nat. Rev. Cancer 3 2003 745 755
6. S. Sarfaraz, F. Afaq, V.M. Adhami, and H. Mukhtar Cannabinoid receptor as a novel target for the treatment of prostate cancer Cancer Res. 65 2005 1635 1641
7. S. Hart, O.M. Fischer, and A. Ullrich Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor Cancer Res. 64 2004 1943 1950
8. J.M. Derocq, M. Segui, J. Marchand, G. Le Fur, and P. Casellas Cannabinoids enhance human B-cell growth at low nanomolar concentrations FEBS Lett. 369 1995 177 182
9. N.E. Kaminski, M.E. Abood, F.K. Kessler, B.R. Martin, and A.R. Schatz Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Mol. Pharmacol. 42 1992 736 742
10. T.W. Klein Cannabinoid-based drugs as anti-inflammatory therapeutics Nat. Rev. Immunol. 5 2005 400 411
11. M. Bifulco, C. Laezza, M. Valenti, A. Ligresti, G. Portella, and D.I.M. Vincenzo A new strategy to block tumor growth by inhibiting endocannabinoid inactivation FASEB J. 18 2004 1606 1608
12. T. Powles, R. te Poele, J. Shamash, T. Chaplin, D. Propper, S. Joel, T. Oliver, and W.M. Liu Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway Blood 105 2005 1214 1221
13. J.M. Derocq, M. Bouaboula, J. Marchand, M. Rinaldi-Carmona, M. Segui, and P. Casellas The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines FEBS Lett. 425 1998 419 425
14. R.J. McKallip, C. Lombard, M. Fisher, B.R. Martin, S. Ryu, S. Grant, P.S. Nagarkatti, and M. Nagarkatti Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2002 627 634
15. I.N. Bojesen, and H.S. Hansen Binding of anandamide to bovine serum albumin J. Lipid Res. 44 2003 1790 1794
16. L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc. Natl. Acad. Sci. USA 95 1998 8375 8380
17. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors J. Biol. Chem. 275 2000 31938 31945
18. R.G. Pertwee Inverse agonism and neutral antagonism at cannabinoid CB1 receptors Life Sci. 76 2005 1307 1324
19. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J. Neurosci. 15 1995 6552 6561
20. W. Jin, S. Brown, J.P. Roche, C. Hsieh, J.P. Celver, A. Kovoor, C. Chavkin, and K. Mackie Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization J. Neurosci. 19 1999 3773 3780
21. D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, M. Bifulco, and V. Di Marzo Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation Endocrinology 141 2000 118 126